AbbVie Inc. Website

AbbVie Inc.

NYSE-ABBV

Basic

  • Market Cap

    $321.69B

  • EV

    $378.02B

  • Shares Out

    1,765.87M

  • Revenue

    $55B

  • Employees

    50,000

Margins

  • Gross

    69.52%

  • EBITDA

    47.73%

  • Operating

    32.35%

  • Pre-Tax

    12.85%

  • Net

    9.71%

  • FCF

    40.62%

Returns (5Yr Avg)

  • ROA

    6.6%

  • ROTA

    -16.49%

  • ROE

    67.23%

  • ROCE

    19%

  • ROIC

    17.43%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $189.26

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    $18.07B

  • Net Debt

    $56.29B

  • Debt/Equity

    9.24

  • EBIT/Interest

    7.9

Growth (CAGR)

  • Rev 3Yr

    0.78%

  • Rev 5Yr

    11.01%

  • Rev 10Yr

    11.06%

  • Dil EPS 3Yr

    -6.92%

  • Dil EPS 5Yr

    1.77%

  • Dil EPS 10Yr

    1.49%

  • Rev Fwd 2Yr

    3.71%

  • EBITDA Fwd 2Yr

    5.39%

  • EPS Fwd 2Yr

    4.29%

  • EPS LT Growth Est

    8.19%

Dividends

  • Yield

    —

  • Payout

    204.58%

  • DPS

    $6.13

  • DPS Growth 3Yr

    6.46%

  • DPS Growth 5Yr

    8.01%

  • DPS Growth 10Yr

    14.09%

  • DPS Growth Fwd 2Yr

    4.2%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Metric
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

33,266

45,804

56,197

58,054

54,318

55,000

Total Revenues % Chg.

1.6%

37.7%

22.7%

3.3%

-6.4%

-1.8%

Cost of Goods Sold, Total

7,439

15,257

17,314

16,527

16,726

16,766

Gross Profit

25,827

30,547

38,883

41,527

37,592

38,234

Selling General & Admin Expenses, Total

6,763

9,867

11,872

12,084

12,904

13,068

R&D Expenses

5,377

6,003

6,820

6,487

7,038

7,376

Other Operating Expenses

—

—

—

-560

—

432

-1

-10

—

Other Operating Expenses, Total

11,580

15,870

19,124

18,570

19,932

20,444

Operating Income

14,247

14,677

19,759

22,957

17,660

17,790

Interest Expense, Total

-1,784

-2,454

-2,423

-2,230

-2,224

-2,251

Interest And Investment Income

275

174

39

186

540

540

Net Interest Expenses

-1,509

-2,280

-2,384

-2,044

-1,684

-1,711

Currency Exchange Gains (Loss)

-42

-71

-51

-148

-146

-79

Other Non Operating Income (Expenses)

9

113

55

142

190

187

EBT, Excl. Unusual Items

12,705

12,439

17,379

20,907

16,020

16,187

Restructuring Charges

—

—

—

—

—

—

—

—

—

—

Merger & Related Restructuring Charges

—

—

—

-103

-1,912

-587

-768

-119

-797

Gain (Loss) On Sale Of Investments

—

—

—

—

—

—

—

—

—

Gain (Loss) On Sale Of Assets

—

—

—

—

—

330

—

—

172

—

—

Asset Writedown

—

-1,030

—

—

-876

-4,230

-3,520

In Process R&D Expenses

-385

-1,376

-1,124

-697

-778

-1,449

Legal Settlements

—

—

—

—

—

—

—

-2,500

485

485

Other Unusual Items

—

—

-3,091

-5,753

-2,679

-2,761

-5,128

-3,840

EBT, Incl. Unusual Items

8,426

3,398

12,989

13,477

6,250

7,066

Income Tax Expense

544

-1,224

1,440

1,632

1,377

1,716

Earnings From Continuing Operations

7,882

4,622

11,549

11,845

4,873

5,350

Minority Interest

—

—

—

—

—

—

-6

-7

-9

-10

-11

Net Income

7,882

4,616

11,542

11,836

4,863

5,339

Preferred Dividend and Other Adjustments

40

60

74

54

43

43

Net Income to Common Incl Extra Items

7,842

4,556

11,468

11,782

4,820

5,296

Net Income to Common Excl. Extra Items

7,842

4,556

11,468

11,782

4,820

5,296

Total Shares Outstanding

1,478.9

1,765.1

1,768.3

1,769.2

1,765.9

1,771

Weighted Avg. Shares Outstanding

1,481

1,667

1,770

1,771

1,768

1,767.5

Weighted Avg. Shares Outstanding Dil

1,484

1,673

1,777

1,778

1,773

1,772.5

EPS

5.3

2.7

6.5

6.7

2.7

3

EPS Diluted

5.3

2.7

6.5

6.6

2.7

3

EBITDA

16,264

21,148

28,280

31,424

26,358

26,249

Effective Tax Rate

6.5%

-36%

11.1%

12.1%

22%

24.3%